Cardinal Health’s sell-off on earnings was an overreaction. We’d be buyers

We’ve taken a closer look at Cardinal Health’s quarterly results and conference call following Thursday’s sell-off. Our conclusion: The 4.9% decline was an overreaction, and

Tag: buyers

Cardinal Health’s sell-off on earnings was an overreaction. We’d be buyers

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Eli Lilly shares surge on a beat-and-raise, proving the stock’s swoon was a mistake

Do Supplements Help You Sleep? Here’s What to Know.

It Felt Like a Pulled Muscle, but the Pain Kept Coming Back

The Gift of Getting Weirder With Age